Palivizumab

ATC J06BD01 · 9 markets · 22 records

Palivizumab 9 markets · 22 records Forms

GB 4 records · 4 strengths

AU 3 records · 3 strengths

  • 100 mginjectionSYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial also in GB unknown
  • 50 mginjectionSYNAGIS palivizumab (rmc) 50 mg / 0.5 mL solution for injection vial also in GB unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

HK 2 records · 1 strengths

    2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名SYNAGIS SOLUTION FOR INJECTION 100MG/1ML ×4

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    FR 2 records · 2 strengths

    • 100 mg/1 mLinjectionSYNAGIS 100 mg/ml, solution injectable also in GB
    • 50 mg/0.5 mLinjectionSYNAGIS 50 mg/0,5 ml, solution injectable also in GB

    SG 1 records · 1 strengths

    • 100 mg/mLinjectionSYNAGIS SOLUTION FOR INJECTION 100MG/ML

    TW 1 records · 1 strengths

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      With a brand name Con nombre comercial 有商品名 有商品名SYNAGIS 100mg/ml solution for injection ×2西那吉斯注射液劑100毫克/毫升 ×2

      Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

      EU 1 records · 1 strengths

      EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

        1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

        Side-by-side table

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.